Professional Documents
Culture Documents
FACILITATE D BY
4/15/12
Satish
ABSORPTION OF DRUGS
Drug Solubility and Dissolution Rate
the two critical slower rate-determining processes in the absorption of orally administered drugs are:
Click of edit Master subtitle style 1. Rate to dissolution, and 2. Rate of drug permeation through the biomembrane.
4/15/12
etermining steps
Dissolution is the RDS for hydrophobic, poorly aqueous soluble drugs like griseofulvin and spironolactone; absorption of such drugs is often said to be dissolution rate-limited. If the drug is hydrophilic with high aqueous solubilityfor example, cromolyn sodium or neomycin, then dissolution is rapid and the RDS in the absorption of such drugs is rate of permeation through thesubtitle style In other words, Click to edit Master biomembrane. absorption of such drugs is said to be permeation rate limited or transmembrane rate limited.
Disintegration deggregation
4/15/12
Dru at the g in absorption site the bod y RDS for RDS for lipophillic drug Hydrophilli
that goes into solution per unit time under standard conditions of temperature, pH and solvent composition and constant solid surface area. it is a dynamic property
4/15/12
4/15/12
Dissolution and ph
Dissolution Increase with increase rate Weak acidMaster subtitle style Click to edit in pH Dissolution rate Increase with decrease in pH
Weak base
4/15/12
2.
3.
Solution of the solid to form a thin film or layer at the solid/ liquid interface called as the stagnant film or diffusion layer which is saturated with the drug; this step is usually Click to and Master subtitle Stagnant layer of thickness h style rapid, edit And concentration Cs Diffusion of the soluble solute from the stagnant layer to the bulk of the solution; this step is slower and is therefore the rate Solid determining step in drug dissolution. Drug It is given by Noyes and Whitney: partie Bulk of the solution with
concentration Cb
4/15/12
Dissolving drug
GI lumen
GI barrrier Blood
dC/dt= k ( C s-Cb ) Click to where.edit Master subtitle style dC/dt = dissolution rate of the drug, k = dissolution rate constant (first order), Cs = concentration of drug in the stagnant layer (also called 4/15/12 as the saturation or maximum
Non-Sink condition
In case of in-vitro dissolution which is done in a limited amount of solvent thus there is drug concentration built up in the bulk of the liquid SINK CONDITION as in case of in-vivo Zero-order dissolution there is less built of under sink conditions Click to edit Master subtitle style concentration in the bulk since the drug first-order dissolution is distributed under sink conditions immediately after the dissolution therefore Thus, under in vivo conditions, there is no concentration build-up in the bulk 4/15/12 time of the solution and
Fresh packet of solvent approaching the packet of solvent inerface saturated with
two assumptions: 1. The rate-determining step that controls dissolution is the mass transport. 2. Solid-solution equilibrium is achieved at the solid/liquid interface. 4/15/12
4/15/12
4/15/12
Polymorp hism
pH
4/15/12
dC/dt = DAKw/p(Cs-Cb)/Vh
4/15/12
Figure shows the effect of particle size of phenobarbital suspensions on the drugs bioavailability after intramuscular injection, compared with a solution of the drug, which probably precipitates in fine crystal form at the site of injection. The rate of solution of the drug crystals controls the extent of absorption from the intramuscular site.
4/15/12
In the case of digoxin there is evidence that milling to reduce particle size can produce an amorphous modification of the drug with enhanced solubility and hence increased bioavailability. Click to edit Master subtitle style The possibility of changing the crystal structure during processing is therefore important: comminution, recrystallisation and drying can all affect crystal properties.
4/15/12
4/15/12
Micronization
From the modified Noyes-Whitney equation it is clear that larger the surface area, higher the dissolution rate. Since the surface area increases with decreasing particle size, a decrease in particle size, which can be accomplished by Click to edit Master subtitle higher micronization, will result instyle dissolution From the modified Noyesrates.
Whitney equation it is clear that larger the surface area, higher the dissolution rate. Since the surface area increases with decreasing particle size, a decrease in 4/15/12 particle size, which can be
Exceptions in Micronization
it is important to note that it is not the absolute surface area but the effective surface area that is proportional to the dissolution rate. Greater the effective surface area, more intimate the contact between the solid surface and the aqueous solvent and faster the dissolution. However, in case of hydrophobic drugs like aspirin, phenacetin and phenobarbital, micronization actually results in a decrease in the Click to edit Master subtitle style effective surface area of such powders and thus, a fall in the dissolution rate. Three reasons have been suggested for such an outcome 1. The hydrophobic surface of the drugs adsorb air onto their surface which inhibit their wettability; such powders float on the dissolution medium. 2. The particles reaggregate to form larger particles due to their high surface free energy, which either float on the surface or settle at the bottom of the dissolution medium. 3. Extreme particle size reduction may impart surface 4/15/12 charges that may prevent wetting; moreover electrically
Solutions
The absolute surface area of hydrophobic drugs can be converted to their effective surface area by: 1 Use of surfactant as a wetting agent that decreases the interfacial tension and displaces the adsorbed air Click to edit Master subtitle style with the solventfor example, tween 80 increases the bioavailability of phenacetin by promoting its wettability, and 2. Adding hydrophilic diluents such as PEG, PVP, dextrose, etc. which coat the surface of hydrophobic drug particles and render them hydrophilic.
4/15/12
Solutions
Particle size reduction and subsequent increase in the surface area and dissolution rate is not always advisable especially when the drugs are unstable and degrade in solution form (penicillin G and erythromycin), produce undesirable effects (gastric irritation caused by nitrofurantoin) or when a sustained effect is desired. In addition to increasing the dissolution rate, the second mechanism by Click toreduction in particle sizestyle which a edit Master subtitle improves drug dissolution is through an increase in its solubility. However, such an effect can only be achieved by reducing the particle size to a submicron level which is possible by use of one of the following specialized techniques such as formation of: 1. Molecular dispersion/solid solution where the sparingly soluble drug is molecularly trapped in the lattice of a hydrophilic agent such as cyclodextrins, or 2. Solid dispersion where such a drug is dispersed in a soluble carrier such as PVP, PEG, urea, etc.
4/15/12
reversibly changed into another form by altering the Click to edit Master subtitle style temperature or pressure e.g. sulfur 2. Monotropic polymorph is the one which is unstable at all temperatures and pressures e.g. glyceryl stearates.
4/15/12
Stable polymorph
Metastable polymorph
Click to edit Master subtitle style Lowest energy, Least solubility, Highest MP low bioavailability
high energy, high solubility, lowest MP better bioavailability No internal structure High energy High solubility
4/15/12
Amorphous drugs
tructure
Crystals contain highly ordered arrays of molecules and atoms held together by noncovalent interactions. We can consider as a simple example the unit cell of an Click to salt, sodium chloride. inorganic edit Master subtitle style
4/15/12
4/15/12
Crystal form
4/15/12
crystal habits
The habit describes the overall shape of the crystal in rather general terms and includes, for example, acicular (needlelike), prismatic, pyramidal, tabular, equant, columnar and lamellar types. The crystal habit can also influence the ease of compression of a tablet and the flow properties of the drug in the solid Click state. to edit Master subtitle style The plate-like crystals of tolbutamide, for example, cause powder bridging in the hopper of the tablet machine and also capping problems during tableting. Neither of these problems occurs with tolbutamide in other crystal habits.
4/15/12
Polymorphism
As we have seen, compounds can crystallize out of solution in a variety of different habits depending on the conditions of crystallisation. These crystal habits usually have the same internal structure and so have the same X-ray diffraction patterns. A Click to edit Master subtitle style more fundamental difference in properties may be found when the compounds crystallise as different polymorphs. When polymorphism occurs, the molecules arrange themselves in two or more different ways in the crystal; either they may be packed differently in the crystal lattice or there may be differences in the orientation or conformation of the molecules at the lattice sites.
4/15/12
Polymorhpism
These variations cause differences in the X-ray diffraction patterns of the polymorphs and this technique is one of the main methods of detecting the existence of polymorphs. The polymorphs have different physical and chemical properties; for example, they may have different melting points and solubilities and they also usually exist in different habits.
4/15/12
Spironolactone
Spironolactone which is a diuretic steroidal aldosterone agonist, crystallizes as two polymorphic forms and also as four solvated crystalline forms depending on the solvents and methods used for crystallization. We will consider the occurrence of solvated forms at the moment we will concentrate on the two polymorphs only.
powder is dissolved in acetone at a temperature very close to the boiling point and the solution is then cooled within a few hours down to 0C.
Form 2
is produced when the powder is dissolved in acetone, dioxane or chloroform at room temperature and the solvent is allowed to spontaneously evaporate over a period of several weeks.
4/15/12
4/15/12
4/15/12
paracetamol
This drug is known to exist in two polymorphic forms, monoclinic (Form 1) and orthorhombic (Form 2), of which Form 1 is the more thermo- dynamically stable at room temperature and is the commercially used form. However, this form is not suitable for direct compression into tablets and has to be mixed with binding agents before Click to procedure that is both costly tableting, aedit Master subtitle style and time-consuming. In contrast, Form 2 can readily undergo plastic deformation upon compaction and it has been suggested that this form may have distinct processing advantages over the monoclinic form. Monoclinic paracetamol is readily produced by crystallization from aqueous solution and many other solvents; production of the orthorhombic form has proved more difficult but may be achieved, at least on a laboratory scale, by nucleating a supersaturated solution of paracetamol with seeds of Form 2 (from melt-crystallised paracetamol).
4/15/12
4/15/12
Eight crystal modifications of phenobarbital have been isolated but 11 have been identified with melting points ranging from 112 to 176C. Of the barbiturates used medicinally, about 70% exhibit polymorphism. The steroids frequently possess polymorphic modifications, testosterone having four: these are Click to edit Master subtitle style cases of true polymorphism and not pseudopolymorphism.
4/15/12
The most important consequence of polymorphism is the possible difference in the bioavailability of different polymorphic forms of a drug; particularly when the drug is poorly soluble. The rate of absorption of such a drug is often dependent upon its rate of dissolution. Click to edit Master subtitle style
Consequences
4/15/12
Of the three polymorphic forms of chloramphenicol palmitate Form A has a low biological activity because it is so slowly hydrolysed in vivo to free chloramphenicol.We can see from Fig. 1.13 that the maximum blood levels attained with 100% Form B polymorph are about seven times greater than with 100% Form A polymorph, and that with mixtures of A and B the blood levels vary in proportion to the percentage of B in the suspension.During formulation development it is vital that sufficient care is taken to determine 4/15/12 polymorphic tendencies of poorly soluble drugs.
4/15/12
Hydrates/Solvates (Pseudopolymorphism)
The stoichiometric type of adducts where the solvent molecules are incorporated in the crystal lattice of the solid are called as the solvates, and the trapped solvent as solvent of crystallization
The solvates can Master different crystalline forms called as Click to edit exist in subtitle style pseudopolymorphs. This phenomenon is called as pscudopolymorphism. When the solvent in association with the drug is water. the solvate is known as a hydrate. Hydrates are most common solvate forms of drugs. Crystals that contain no water of crystallisation are termed anhydrates.
4/15/12
Crystal solvates exhibit a wide range of behaviour depending on the interaction between the solvent and the crystal structure. With some solvates the solvent plays a key role in holding the crystal together; for Click to edit Master subtitle hydrogen-bonded example, it may be part of a style network within the crystal structure. These solvates are very stable and are difficult to desolvate. When these crystals lose their solvent they collapse and recrystallise in a new crystal form. We can think of these as polymorphic solvates.
In other solvates, the solvent is not part of 4/15/12 the crystal bonding and merely occupies
spironolactone
spironolactone which we considered earlier. As well as the two polymorphs, this compound also possesses four solvates, depending onClick to editcrystallized from style whether it is Master subtitle acetonitrile, ethanol, ethyl acetate or methanol. Each of these solvates is transformed to the polymorphic Form 2 on heating, indicating that the solvent is involved in the bonding of the crystal lattice.
4/15/12
Modification of the solvent of crystallization may result in different solvated forms. This is of particular relevance because the hydrated and anhydrous forms of a drug can have melting points and solubilities sufficiently different to affect their pharmaceutical behaviour. Click to edit Master subtitle style For example,
MP 83 68
4/15/12
Hydrates/Solvates (Pseudopolymorphism)
The anhydrous form of theophylline and ampicillin have higher aqueous solubilities, dissolve at a faster rate and show better bioavailability in comparison to their monohydrate and trihydrate forms respectively. 2. On the other hand, the organic (nonaqueous) solvates have greater aqueous solubility than the Click to edit Master subtitle style nonsolvatesfor example, the n-pentanol solvate of Drug Solvate Form Hydrate Solubility fludrocortisone and succinylsulfathiazole and the form chloroform solvate of griseofulvin are more waterAmpicillin,theophylline Anhydrous Faster Ampicillin,theophylline Hydrates Mono or tri Low soluble than their nonsolvated forms. Like polymorphs, the solvates too differ from each other Exceptions stated below in terms of their physical properties.
1.
Flurocortisone Flurocortisone
4/15/12
n-pentol -
Faster Low
4/15/12
Dissolution
Click to edit Master subtitle style Bulk of the Diffusion layer solution higher pH(5-6) relatively lower pH(1-3) Salt of weak acid
4/15/12
Mechanism 1
Consider the case of a salt of a weak acid. At any given pH of the bulk of the solution, the pH of the diffusion layer (saturation solubility of the drug) of the salt form of a weak acid will be higher than that Click to edit Master subtitle style observable with the free acid form of the drug (can be practically observed in the laboratory). Owing to the increased pH of the diffusion layer, the solubility and dissolution rate of a weak acid in this layer is promoted, since it is a known fact that higher pH favors the dissolution of weak acids. Thus, if dissolution is faster, absorption is bound to be rapid. In case of salts of weak bases, the pH of the diffusion layer will be lower in comparison to 4/15/12 that found with the free base form of the drug.
Mechanism 2
Yet another convincing reason for enhanced solubility of salts of weak acids is the precipitation of the drug as very fine particles. When the soluble ionic form of the Click to edit Master stagnant diffusion layer into the drug diffuses from thesubtitle style bulk of the solution whose pH is low, it is transformed into its free acid form having lesser aqueous solubility at the lower pH of the bulk solution. Consequently, this free acidic form of the drug is precipitated in the form of fine particles. The resultant increase in the surface area is then responsible for the rapid dissolution and absorption in comparison to the drug administered in just the acidic form. 4/15/12
Drug pKa and Lipophilicity and Gl pHpH Partition Hypothesis in solution that exists in the The fraction of drug
nonionised form is the function of both the dissociation constant of the drug and pH of the solution. Click to edit Master subtitle style for weak acids. PH = pKa+log
4/15/12
Unioniz ed form
ionized form
High pH
4/15/12
Ionisation
Since most drugs are weak electrolytes (weak acids or weak bases), their degree of ionization depends upon the pH of the biological fluid. If the pH on either side on the membrane is different, then the compartment whose pH favors greater ionization of the drug will contain greater amount Master subtitle styleunionized or Click to edit of drug, and only the undissociated fraction of drug
1. The GIT is a simple lipoidal barrier to the transport of drug. 2. Larger the fraction of unionized drug, faster the absorption. 3. Greater the lipophilicity (K0/w) of the unionized drug, better the absorption 4/15/12
Imporatance of Ionization
The pH of urine may be adjusted (for example by administration of ammonium chloride or sodium bicarbonate) in cases of overdosing with amfetamines, barbiturates, narcotics and salicylates, to ensure that these Click to completely subtitle style drugs are edit Master ionised and hence readily excreted. Conversely, the pH of the urine may be altered to prevent ionisation of a drug in cases where reabsorption is required for therapeutic reasons. Sulfonamide crystalluria may also be avoided by making the urine alkaline.
4/15/12
Henderson-Hasselbach equations: for weak acids. PH = pKa+log (ionized drug concentration/ unionized drug concentration) 4/15/12 % Drug Ionized = (10pH-pKa/1+10pH-
4/15/12
4/15/12
Salts of weak acids or bases are essentially completely ionised in solution. For example, ephedrine hydrochloride (salt of Click to base ephedrine, and the the weakedit Master subtitle style strong acid HCl) exists in aqueous solution in the form of the conjugate acid of the weak base, C6H5CH(OH)CH(CH3) N!H2CH3, together with its Cl- counterions. In a similar manner, when sodium salicylate (salt of the weak acid salicylic acid, and the strong base NaOH) is dissolved in water, it ionises almost entirely into the conjugate base of salicylic acid, 4/15/12
4/15/12
Calculate the percentage of cocaine existing as the free base in a solution of cocaine hydrochloride at subtitle style Click to edit Master pH 4.5, and at pH 8.0. The pKb of cocaine is 5.6.
4/15/12
Phenytoin, Weakly pKa>8 Un-ionised Click to edit Ethosuxamide acidic Master subtitle style Aspirin Moderately 2.5-7.5 Acidic
cromolyn sodium
Strongly acidic
Ionized
4/15/12
subtitle
Mecamylamin
Strong 11 base
4/15/12
4/15/12
4/15/12